FDA Clears Breztri for Asthma Use - Poll - MDSpire

FDA Clears Breztri for Asthma Use

Single-inhaler triple therapy improved lung function vs dual therapy in phase 3 trials and showed rapid onset without new safety signals.

  • By

  • Kathryn Wighton

  • April 28, 2026

  • 2 min

Share

Original Source(s)

FDA Clears Breztri for Asthma Use

  • by Kathryn Wighton

  • April 28, 2026

Related Content

CT Use May Add to Future Cancer Burden

Researchers projected approximately 103,000 future cancers associated with computed tomography examinations performed in the US in 2023.

AI Drafts Cut Radiograph Reporting Time

Prospective cohort study found faster documentation, with no statistically significant difference in peer-reviewed report quality

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.